Medical artificial intelligence app gets FDA approval
Medical artificial intelligences (MAA) has received FDA approval for a clinical trial for patients with type 2 diabetes.The agency has approved the use of the MAA platform to develop algorithms for detecting and monitoring blood glucose in patients.The study is part of an effort by the National Institutes of Health (NIH) to improve patient care by enabling clinicians to develop
Read More